{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:25:13Z","timestamp":1756383913095},"reference-count":62,"publisher":"Japan Society of Histochemistry & Cytochemistry","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Histochem. Cytochem.","Acta Histochemica et Cytochemica","Acta Histochem. Cytochem"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1267\/ahc.14025","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T23:23:52Z","timestamp":1405466632000},"page":"133-143","source":"Crossref","is-referenced-by-count":5,"title":["New Insights into Therapeutic Strategies for the Treatment of Peritoneal Fibrosis: Learning from Histochemical Analyses of Animal Models"],"prefix":"10.1267","volume":"47","author":[{"given":"Mineaki","family":"Kitamura","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Nishino","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Obata","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University School of Medicine"},{"name":"Medical Education Development Center, Nagasaki University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Ozono","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Koji","sequence":"additional","affiliation":[{"name":"Department of Histology and Cell Biology, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kohno","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Nagasaki University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"334","reference":[{"key":"1","unstructured":"1 Alhamdani, M. S., Al-Kassir, A. H., Abbas, F. K., Jaleel, N. A. and Al-Taee, M. F. (2007) Antiglycation and antioxidant effect of carnosine against glucose degradation products in peritoneal mesothelial cells. Nephron Clin. Pract. 107; 26\u201334."},{"key":"2","unstructured":"2 Arai, H., Furusu, A., Nishino, T., Obata, Y., Nakazawa, Y., Nakazawa, M., Hirose, M., Abe, K., Koji, T. and Kohno, S. (2011) Thalidomide prevents the progression of peritoneal fibrosis in mice. Acta Histochem. Cytochem. 44; 51\u201360."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Aroeira, L. S., Aguilera, A., S\u00e1nchez-Tomero, J. A., Bajo, M. A., del Peso, G., Jim\u00e9nez-Heffernan, J. A., Selgas, R. and L\u00f3pez-Cabrera, M. (2007) Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J. Am. Soc. Nephrol. 18; 2004\u20132013.","DOI":"10.1681\/ASN.2006111292"},{"key":"4","unstructured":"4 Augustine, T., Brown, P. W., Davies, S. D., Summers, A. M. and Wilkie, M. E. (2009) Encapsulating peritoneal sclerosis: clinical significance and implications. Nephron Clin. Pract. 111; 149\u2013154."},{"key":"5","unstructured":"5 Bertoli, S. V., Barone, M. T., Vago, L., Bonetto, S., De Vecchi, A., Scalamogna, A. and Barbiano di Belgiojoso, G. (1999) Changes in peritoneal membrane after continuous ambulatory peritoneal dialysis\u2014a histopathological study. Adv. Perit. Dial. 15; 28\u201331."},{"key":"6","unstructured":"6 Bodenham, T., Topley, N. and Fraser, D. (2013) Peritoneal fibrosis is mouse strain dependent. Nephrol. Dial. Transplant. 28; 1966\u20131969."},{"key":"7","unstructured":"7 Border, W. and Noble, N. (1994) Transforming growth factor \u03b2 in tissue fibrosis. N. Engl. J. Med. 331; 1286\u20131292."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Boulanger, E., Wautier, M. P., Wautier, J. L., Boval, B., Panis, Y., Wernert, N., Danze, P. M. and Dequiedt, P. (2002) AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int. 61; 148\u2013156.","DOI":"10.1046\/j.1523-1755.2002.00115.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Boulanger, E., Grossin, N., Wautier, M. P., Taamma, R. and Wautier, J. L. (2007) Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation. Kidney Int. 71; 126\u2013133.","DOI":"10.1038\/sj.ki.5002016"},{"key":"10","unstructured":"10 Bozkurt, D., Hur, E., Ulkuden, B., Sezak, M., Nar, H., Purclutepe, O., Sen, S. and Duman, S. (2009) Can N-acetylcysteine preserve peritoneal function and morphology in encapsulating peritoneal sclerosis? Perit. Dial. Int. 29; 202\u2013205."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Bozkurt, D., Sarsik, B., Hur, E., Ertilav, M., Karaca, B., Timur, O., Bicak, S., Akcicek, F. and Duman, S. (2011) A novel angiogenesis inhibitor, sunitinib malate, in encapsulating peritoneal sclerosis. J. Nephrol. 24; 359\u2013365.","DOI":"10.5301\/JN.2011.6257"},{"key":"12","unstructured":"12 Bozkurt, D., Sipahi, S., Cetin, P., Hur, E., Ozdemir, O., Ertilav, M., Sen, S. and Duman, S. (2009) Does immunosuppressive treatment ameliorate morphology changes in encapsulating peritoneal sclerosis? Perit. Dial. Int. 29; 206\u2013210."},{"key":"13","unstructured":"13 Braun, N., Alscher, M. D., Kimmel, M., Amann, K. and B\u00fcttner, M. (2011) Encapsulating peritoneal sclerosis\u2014an overview. Nephrol. Ther. 7; 162\u2013171."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Chin, A. I. and Yeun, J. Y. (2006) Encapsulating peritoneal sclerosis: an unpredictable and devastating complication of peritoneal dialysis. Am. J. Kidney Dis. 47; 697\u2013712.","DOI":"10.1053\/j.ajkd.2005.12.049"},{"key":"15","unstructured":"15 De Vriese, A. S., Flyvbjerg, A., Mortier, S., Tilton, R. G. and Lameire, N. H. (2003) Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane. J. Am. Soc. Nephrol. 14; 2109\u20132118."},{"key":"16","unstructured":"16 De Vriese, A. S. (2005) The John F. Maher Recipient Lecture 2004: RAGE in the peritoneum. Perit. Dial. Int. 25; 8\u201311."},{"key":"17","unstructured":"17 Devuyst, O., Margetts, P. J. and Topley, N. (2010) The pathophysiology of the peritoneal membrane. J. Am. Soc. Nephrol. 21; 1077\u20131085."},{"key":"18","unstructured":"18 Duman, S., Sen, S., Duman, C. and Oreopoulos, D. G. (2005) Effect of valsartan versus lisinopril on peritoneal sclerosis in rats. Int. J. Artif. Organs 28; 156\u2013163."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Fang, C. C., Huang, J. W., Shyu, R. S., Yen, C. J., Shiao, C. H., Chiang, C. K., Hu, R. H. and Tsai, T. J. (2012) Fibrin-induced epithelial-to-mesenchymal transition of peritoneal mesothelial cells as a mechanism of peritoneal fibrosis: effects of pentoxifylline. PLoS One 7; e44765.","DOI":"10.1371\/journal.pone.0044765"},{"key":"20","unstructured":"20 Hirahara, I., Kusano, E., Yanagiba, S., Miyata, Y., Ando, Y., Muto, S. and Asano, Y. (2006) Peritoneal injury by methylglyoxal in peritoneal dialysis. Perit. Dial. Int. 26; 380\u2013392."},{"key":"21","unstructured":"21 Hirahara, I., Ishibashi, Y., Kaname, S., Kusano, E. and Fujita, T. (2009) Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats. Nephrol. Dial. Transplant. 24; 437\u2013447."},{"key":"22","unstructured":"22 Hirose, M., Nishino, T., Obata, Y., Nakazawa, M., Nakazawa, Y., Furusu, A., Abe, K., Miyazaki, M., Koji, T. and Kohno, S. (2013) 22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model. Perit. Dial. Int. 33; 132\u2013142."},{"key":"23","unstructured":"23 Hoff, C. M. (2005) Experimental animal models of encapsulating peritoneal sclerosis. Perit. Dial. Int. 25; 57\u201366."},{"key":"24","unstructured":"24 Hur, E., Bozkurt, D., Timur, O., Bicak, S., Sarsik, B., Akcicek, F. and Duman, S. (2012) The effects of mycophenolate mofetil on encapsulated peritoneal sclerosis model in rats. Clin. Nephrol. 77; 1\u20137."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Io, H., Hamada, C., Ro, Y., Ito, Y., Hirahara, I. and Tomino, Y. (2004) Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. Kidney Int. 65; 1927\u20131936.","DOI":"10.1111\/j.1523-1755.2004.00599.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Io, K., Nishino, T., Obata, Y., Kitamura, M., Koji, T. and Kohno, S. (2014) SAHA prevents the progression of peritoneal fibrosis in mice. <i>Perit. Dial. Int.<\/i> (Epub ahed of print).","DOI":"10.3747\/pdi.2013.00089"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Kawaguchi, Y. and Tranaeus, A. (2005) A historical review of encapsulating peritoneal sclerosis. Perit. Dial Int. 25; 7\u201313.","DOI":"10.1177\/089686080502504S02"},{"key":"28","unstructured":"28 Kawaguchi, Y., Saito, A., Kawanishi, H., Nakayama, M., Miyazaki, M., Nakamoto, H. and Tranaeus, A. (2005) Recom\u00admendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treat\u00adment, and preventive measures. Perit. Dial. Int. 25; 83\u201395."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Kawanishi, H., Kawaguchi, Y., Fukui, H., Hara, S., Imada, A., Kubo, H., Kin, M., Nakamoto, M., Ohira, S. and Shoji, T. (2004) Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am. J. Kidney Dis. 44; 729\u2013737.","DOI":"10.1016\/S0272-6386(04)00953-9"},{"key":"30","unstructured":"30 Kawanishi, H., Watanabe, H., Moriishi, M. and Tsuchiya, S. (2005) Successful surgical management of encapsulating peritoneal sclerosis. Perit. Dial. Int. 25; 39\u201347."},{"key":"31","unstructured":"31 Kihm, L. P., Wibisono, D., M\u00fcller-Krebs, S., Pfisterer, F., Morath, C., Gross, M. L., Morcos, M., Seregin, Y., Bierhaus, A., Nawroth, P. P., Zeier, M. and Schwenger, V. (2008) RAGE expression in the human peritoneal membrane. Nephrol. Dial. Transplant. 23; 3302\u20133306."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Kitamura, M., Nishino, T., Obata, Y., Furusu, A., Hishikawa, Y., Koji, T. and Kohno, S. (2012) Epigallocatechin gallate suppresses peritoneal fibrosis in mice. Chem. Biol. Interact. 195; 95\u2013104.","DOI":"10.1016\/j.cbi.2011.11.002"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Koji, T., Komuta, K., Nozawa, M., Yamada, S. and Nakane, P. K. (1994) Localization of cyclic adenosine 3&apos;,5&apos;-monophosphate-responsive element (CRE)-binding proteins by southwestern histochemistry. J. Histochem. Cytochem. 42; 1399\u20131405.","DOI":"10.1177\/42.10.7930523"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Korte, M. R., Fieren, M. W., Sampimon, D. E., Lingsma, H. F., Weimar, W., Betjes, M. G. and investigators of multicenter of the Dutch Multicentre EPS Study (2011) Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study. Nephrol. Dial. Transplant. 26; 691\u2013697.","DOI":"10.1093\/ndt\/gfq362"},{"key":"35","unstructured":"35 Korte, M. R., Sampimon, D. E., Betjes, M. G. and Krediet, R. T. (2011) Encapsulating peritoneal sclerosis: the state of affairs. Nat. Rev. Nephrol. 7; 528\u2013538."},{"key":"36","unstructured":"36 Kushiyama, T., Oda, T., Yamada, M., Higashi, K., Yamamoto, K., Oshima, N., Sakurai, Y., Miura, S. and Kumagai, H. (2011) Effects of liposome-encapsulated clodronate on chlorhexidine gluconate-induced peritoneal fibrosis in rats. Nephrol. Dial. Transplant. 26; 3143\u20133154."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Loureiro, J., Sandoval, P., del Peso, G., G\u00f3nzalez-Mateo, G., Fern\u00e1ndez-Millara, V., Santamaria, B., Bajo, M. A., S\u00e1nchez-Tomero, J. A., Guerra-Azcona, G., Selgas, R., L\u00f3pez-Cabrera, M. and Aguilera, A. I. (2013) Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis. PLoS One 8; e61165.","DOI":"10.1371\/journal.pone.0061165"},{"key":"38","unstructured":"38 McLoughlin, R. M. and Topley, N. (2011) Switching on EMT in the peritoneal membrane: considering the evidence. Nephrol. Dial. Transplant. 26; 12\u201315."},{"key":"39","unstructured":"39 Mishima, Y., Miyazaki, M., Abe, K., Ozono, Y., Shioshita, K., Xia, Z., Harada, T., Taguchi, T., Koji, T. and Kohno, S. (2003) Enhanced expression of heat shock protein 47 in rat model of peritoneal fibrosis. Perit. Dial. Int. 23; 14\u201322."},{"key":"40","unstructured":"40 Mondello, S., Mazzon, E., Di Paola, R., Crisafulli, C., Italiano, D., Buemi, M., Aloisi, C. and Cuzzocrea, S. (2009) Erythropoietin suppresses peritoneal fibrosis in rat experimental model. Eur. J. Pharmacol. 604; 138\u2013149."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Nagata, K. (2003) Therapeutic strategy for fibrotic diseases by \u200dregulating the expression of collagen-specific molecular chaperone HSP47. Nihon Yakurigaku Zasshi 121; 4\u201314.","DOI":"10.1254\/fpj.121.4"},{"key":"42","unstructured":"42 Nakamoto, H., Kawaguchi, Y. and Suzuki, H. (2002) Encapsulating peritoneal sclerosis in patients undergoing continuous ambulatory peritoneal dialysis in Japan. Adv. Perit. Dial. 18; 119\u2013123."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Nakayama, M., Sakai, A., Numata, M. and Hosoya, T. (2003) Hyper-vascular change and formation of advanced glycation endproducts in the peritoneum caused by methylglyoxal and the effect of an anti-oxidant, sodium sulfite. Am. J. Nephrol. 23; 390\u2013394.","DOI":"10.1159\/000074065"},{"key":"44","unstructured":"44 Nakazawa, M., Obata, Y., Nishino, T., Abe, S., Nakazawa, Y., Abe, K., Furusu, A., Miyazaki, M., Koji, T. and Kohno, S. (2013) Involvement of leptin in the progression of experimentally induced peritoneal fibrosis in mice. Acta Histochem. Cytochem. 46; 75\u201384."},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Nessim, S. J., Perl, J. and Bargman, J. M. (2010) The renin-angiotensin-aldosterone system in peritoneal dialysis: is what is good for the kidney also good for the peritoneum? Kidney Int. 78; 23\u201328.","DOI":"10.1038\/ki.2010.90"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Nishino, T., Miyazaki, M., Abe, K., Furusu, A., Mishima, Y., Harada, T., Ozono, Y., Koji, T. and Kohno, S. (2003) Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats. Kidney Int. 64; 887\u2013896.","DOI":"10.1046\/j.1523-1755.2003.00169.x"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Nishino, T., Ashida, R., Obata, Y., Furusu, A., Abe, K., Miyazaki, M., Koji, T. and Kohno, S. (2012) Involvement of lymphocyte infiltration in the progression of mouse peritoneal fibrosis model. Ren. Fail. 34; 760\u2013766.","DOI":"10.3109\/0886022X.2012.676527"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Obata, Y., Nishino, T., Kushibiki, T., Tomoshige, R., Xia, Z., Miyazaki, M., Abe, K., Koji, T., Tabata, Y. and Kohno, S. (2012) HSP47 siRNA conjugated with cationized gelatin microspheres suppresses peritoneal fibrosis in mice. Acta Biomater. 8; 2688\u20132696.","DOI":"10.1016\/j.actbio.2012.03.050"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Park, S. H., Kim, Y. L. and Lindholm, B. (2008) Experimental encapsulating peritoneal sclerosis models: pathogenesis and treatment. Perit. Dial. Int. 28; S21\u201328.","DOI":"10.1177\/089686080802805S05"},{"key":"50","unstructured":"50 Pletinck, A., Van Landschoot, M., Steppan, S., Laukens, D., Passlick-Deetjen, J., Vanholder, R. and Van Biesen, W. (2012) Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion. Nephrol. Dial. Transplant. 27; 548\u2013556."},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Sampimon, D. E., Korte, M. R., Barreto, D. L., Vlijm, A., de Waart, R., Struijk, D. G. and Krediet, R. T. (2010) Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study. Perit. Dial. Int. 30; 163\u2013169.","DOI":"10.3747\/pdi.2009.00022"},{"key":"52","unstructured":"52 Sandoval, P., Loureiro, J., Gonz\u00e1lez-Mateo, G., P\u00e9rez-Lozano, M. L., Maldonado-Rodr\u00edguez, A., S\u00e1nchez-Tomero, J. A., Mendoza, L., Santamar\u00eda, B., Ortiz, A., Ru\u00edz-Ortega, M., Selgas, R., Mart\u00edn, P., S\u00e1nchez-Madrid, F., Aguilera, A. and L\u00f3pez-Cabrera, M. (2010) PPAR-\u03b3 agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage. Lab. Invest. 90; 1517\u20131532."},{"key":"53","unstructured":"53 Sawada, T., Ishii, Y., Tojimbara, T., Nakajima, I., Fuchinoue, S. and Teraoka, S. (2002) The ACE inhibitor, quinapril, ameliorates peritoneal fibrosis in an encapsulating peritoneal sclerosis model in mice. Pharmacol. Res. 46; 505\u2013510."},{"key":"54","unstructured":"54 Sawai, A., Ito, Y., Mizuno, M., Suzuki, Y., Toda, S., Ito, I., Hattori, R., Matsukawa, Y., Gotoh, M., Takei, Y., Yuzawa, Y. and Matsuo, S. (2011) Peritoneal macrophage infiltration is correlated with baseline peritoneal solute transport rate in peritoneal dialysis patients. Nephrol. Dial. Transplant. 26; 2322\u20132332."},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Schwenger, V. (2006) GDP and AGE receptors: mechanisms of peritoneal damage. Contrib. Nephrol. 150; 77\u201383.","DOI":"10.1159\/000093505"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Shin, M., Hishikawa, Y., Izumi, S. and Koji, T. (2002) Southwestern histochemistry as a molecular histochemical tool for analysis of expression of transcription factors: application to paraffin-embedded tissue sections. Med. Electron. Microsc. 35; 217\u2013224.","DOI":"10.1007\/s007950200025"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Shioshita, K., Miyazaki, M., Ozono, Y., Abe, K., Taura, K., Harada, T., Koji, T., Taguchi, T. and Kohno, S. (2000) Expression of heat shock proteins 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis. Kidney Int. 57; 619\u2013631.","DOI":"10.1046\/j.1523-1755.2000.00883.x"},{"key":"58","unstructured":"58 Suga, H., Teraoka, S., Ota, K., Komemushi, S., Furutani, S., Yamauchi, S. and Margolin, S. (1995) Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats. Exp. Toxicol. Pathol. 47; 287\u2013291."},{"key":"59","unstructured":"59 Takahashi, S., Taniguchi, Y., Nakashima, A., Arakawa, T., Kawai, T., Doi, S., Ito, T., Masaki, T., Kohno, N. and Yorioka, N. (2009) Mizoribine suppresses the progression of experimental peritoneal fibrosis in a rat model. Nephron Exp. Nephrol. 112; 59\u201369."},{"key":"60","doi-asserted-by":"crossref","unstructured":"60 Tanabe, K., Maeshima, Y., Ichinose, K., Kitayama, H., Takazawa, Y., Hirokoshi, K., Kinomura, M., Sugiyama, H. and Makino, H. (2007) Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model. Kidney Int. 71; 227\u2013238.","DOI":"10.1038\/sj.ki.5002040"},{"key":"61","unstructured":"61 Williams, J. D., Craig, K. J., Topley, N., Von Ruhland, C., Fallon, M., Newman, G. R., Mackenzie, R. K., Williams, G. T. and Group, P. B. S. (2002) Morphologic changes in the peritoneal membrane of patients with renal disease. J. Am. Soc. Nephrol. 13; 470\u2013479."},{"key":"62","unstructured":"62 Yoshio, Y., Miyazaki, M., Abe, K., Nishino, T., Furusu, A., Mizuta, Y., Harada, T., Ozono, Y., Koji, T. and Kohno, S. (2004) TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. <i>Kidney Int.<\/i> 66; 1677\u20131685."}],"container-title":["ACTA HISTOCHEMICA ET CYTOCHEMICA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ahc\/47\/4\/47_14025\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T06:37:06Z","timestamp":1616999826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ahc\/47\/4\/47_14025\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1267\/ahc.14025","relation":{},"ISSN":["0044-5991","1347-5800"],"issn-type":[{"value":"0044-5991","type":"print"},{"value":"1347-5800","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}